135 related articles for article (PubMed ID: 22178713)
1. Expression of infection-related genes in parasites and host during murine experimental infection with Leishmania (Leishmania) amazonensis.
Pereira BA; Britto C; Alves CR
Microb Pathog; 2012 Feb; 52(2):101-8. PubMed ID: 22178713
[TBL] [Abstract][Full Text] [Related]
2. Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response.
Alexander J; Coombs GH; Mottram JC
J Immunol; 1998 Dec; 161(12):6794-801. PubMed ID: 9862710
[TBL] [Abstract][Full Text] [Related]
3. Partial protective responses induced by a recombinant cysteine proteinase from Leishmania (Leishmania) amazonensis in a murine model of cutaneous leishmaniasis.
Fedeli CE; Ferreira JH; Mussalem JS; Longo-Maugéri IM; Gentil LG; dos Santos MR; Katz S; Barbiéri CL
Exp Parasitol; 2010 Feb; 124(2):153-8. PubMed ID: 19735658
[TBL] [Abstract][Full Text] [Related]
4. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR
Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
[TBL] [Abstract][Full Text] [Related]
5. In silico predicted epitopes from the COOH-terminal extension of cysteine proteinase B inducing distinct immune responses during Leishmania (Leishmania) amazonensis experimental murine infection.
Pereira BA; Silva FS; Rebello KM; Marín-Villa M; Traub-Cseko YM; Andrade TC; Bertho ÁL; Caffarena ER; Alves CR
BMC Immunol; 2011 Aug; 12():44. PubMed ID: 21824434
[TBL] [Abstract][Full Text] [Related]
6. Mast cells are activated by Leishmania mexicana LPG and regulate the disease outcome depending on the genetic background of the host.
Villaseñor-Cardoso MI; Salaiza N; Delgado J; Gutiérrez-Kobeh L; Pérez-Torres A; Becker I
Parasite Immunol; 2008 Aug; 30(8):425-34. PubMed ID: 18507782
[TBL] [Abstract][Full Text] [Related]
7. Late cutaneous metastases in C3H SCID mice infected with Leishmania amazonensis.
Vanloubbeeck Y; Ackermann MR; Jones DE
J Parasitol; 2005 Feb; 91(1):226-8. PubMed ID: 15856912
[TBL] [Abstract][Full Text] [Related]
8. Protection of C3HeB/FeJ mice against Leishmania amazonensis challenge after previous Leishmania major infection.
Vanloubbeeck Y; Jones DE
Am J Trop Med Hyg; 2004 Oct; 71(4):407-11. PubMed ID: 15516635
[TBL] [Abstract][Full Text] [Related]
9. Immunopathological studies of Leishmania amazonensis infection in resistant and in susceptible mice.
de Oliveira Cardoso F; de Souza Cda S; Mendes VG; Abreu-Silva AL; Gonçalves da Costa SC; Calabrese KS
J Infect Dis; 2010 Jun; 201(12):1933-40. PubMed ID: 20462353
[TBL] [Abstract][Full Text] [Related]
10. The histopathological and immunological pattern of CBA mice infected with Leishmania amazonensis after treatment with pyrazole carbohydrazide derivatives.
Charret KS; Lagrota-Cândido J; Carvalho-Pinto CE; Hottz CF; Lira ML; Rodrigues RF; Gomes AO; Bernardino AM; Canto-Cavalheiro MM; Leon LL; Amaral VF
Exp Parasitol; 2013 Feb; 133(2):201-10. PubMed ID: 23219949
[TBL] [Abstract][Full Text] [Related]
11. Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis.
Zadeh-Vakili A; Taheri T; Taslimi Y; Doustdari F; Salmanian AH; Rafati S
Vaccine; 2004 May; 22(15-16):1930-40. PubMed ID: 15121305
[TBL] [Abstract][Full Text] [Related]
12. Ocular experimental leishmaniasis in C57BL/10 and BALB/c mice induced by Leishmania amazonensis infection.
Calabrese KS; Silva LS; Hardoim DJ; Souza CS; Abreu-Silva AL
Exp Parasitol; 2013 Feb; 133(2):156-61. PubMed ID: 23201219
[TBL] [Abstract][Full Text] [Related]
13. Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection.
Soong L; Chang CH; Sun J; Longley BJ; Ruddle NH; Flavell RA; McMahon-Pratt D
J Immunol; 1997 Jun; 158(11):5374-83. PubMed ID: 9164958
[TBL] [Abstract][Full Text] [Related]
14. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
[TBL] [Abstract][Full Text] [Related]
15. Leishmania amazonensis: participation of regulatory T and B cells in the in vitro priming (PIV) of CBA/J spleen cells susceptible response.
Veras PS; Welby-Borges M; de Santana CD; Nihei J; Cardillo F; de Freitas LA
Exp Parasitol; 2006 Jul; 113(3):201-5. PubMed ID: 16516200
[TBL] [Abstract][Full Text] [Related]
16. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
[TBL] [Abstract][Full Text] [Related]
17. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?
McMahon-Pratt D; Alexander J
Immunol Rev; 2004 Oct; 201():206-24. PubMed ID: 15361243
[TBL] [Abstract][Full Text] [Related]
18. Leishmania amazonensis: humoral response to amastigote excreted-antigens in murine leishmaniasis.
Hernández-Chinea C
Exp Parasitol; 2007 Aug; 116(4):492-6. PubMed ID: 17349625
[TBL] [Abstract][Full Text] [Related]
19. A role for gamma delta + T cells during experimental infection of mice with Leishmania major.
Rosat JP; MacDonald HR; Louis JA
J Immunol; 1993 Jan; 150(2):550-5. PubMed ID: 8419488
[TBL] [Abstract][Full Text] [Related]
20. Leishmania (Leishmania) amazonensis infection in mice treated with FTY720.
Lopes CT; de Paula DM; Cury PM; Valero-Lapchik VB; Bueno V
Transplant Proc; 2010 Mar; 42(2):578-81. PubMed ID: 20304196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
